CHGCF
Price
$46.69
Change
-$5.18 (-9.99%)
Updated
Jul 3 closing price
Capitalization
49.42B
CMOPF
Price
$64.37
Change
+$9.37 (+17.04%)
Updated
May 28 closing price
Capitalization
827.91M
Interact to see
Advertisement

CHGCF vs CMOPF

Header iconCHGCF vs CMOPF Comparison
Open Charts CHGCF vs CMOPFBanner chart's image
Chugai Pharmaceutical
Price$46.69
Change-$5.18 (-9.99%)
Volume$2.14K
Capitalization49.42B
Cosmo Pharmaceuticals
Price$64.37
Change+$9.37 (+17.04%)
Volume$200
Capitalization827.91M
CHGCF vs CMOPF Comparison Chart in %
Loading...
CHGCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHGCF vs. CMOPF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHGCF is a Hold and CMOPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CHGCF: $46.69 vs. CMOPF: $64.37)
Brand notoriety: CHGCF and CMOPF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHGCF: 48% vs. CMOPF: 100%
Market capitalization -- CHGCF: $49.42B vs. CMOPF: $827.91M
CHGCF [@Pharmaceuticals: Major] is valued at $49.42B. CMOPF’s [@Pharmaceuticals: Major] market capitalization is $827.91M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHGCF’s FA Score shows that 0 FA rating(s) are green whileCMOPF’s FA Score has 1 green FA rating(s).

  • CHGCF’s FA Score: 0 green, 5 red.
  • CMOPF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHGCF is a better buy in the long-term than CMOPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHGCF’s TA Score shows that 3 TA indicator(s) are bullish while CMOPF’s TA Score has 4 bullish TA indicator(s).

  • CHGCF’s TA Score: 3 bullish, 6 bearish.
  • CMOPF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, CMOPF is a better buy in the short-term than CHGCF.

Price Growth

CHGCF (@Pharmaceuticals: Major) experienced а -14.25% price change this week, while CMOPF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCF($49.4B) has a higher market cap than CMOPF($828M). CMOPF has higher P/E ratio than CHGCF: CMOPF (68.49) vs CHGCF (20.79). CHGCF YTD gains are higher at: 11.886 vs. CMOPF (-3.818). CHGCF has higher annual earnings (EBITDA): 458B vs. CMOPF (42.1M). CHGCF has more cash in the bank: 665B vs. CMOPF (222M). CMOPF has less debt than CHGCF: CMOPF (176M) vs CHGCF (215M). CHGCF has higher revenues than CMOPF: CHGCF (1.24T) vs CMOPF (104M).
CHGCFCMOPFCHGCF / CMOPF
Capitalization49.4B828M5,966%
EBITDA458B42.1M1,087,886%
Gain YTD11.886-3.818-311%
P/E Ratio20.7968.4930%
Revenue1.24T104M1,196,154%
Total Cash665B222M299,550%
Total Debt215M176M122%
FUNDAMENTALS RATINGS
CHGCF vs CMOPF: Fundamental Ratings
CHGCF
CMOPF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
4189
PRICE GROWTH RATING
1..100
5461
P/E GROWTH RATING
1..100
6597
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMOPF's Valuation (15) in the null industry is somewhat better than the same rating for CHGCF (74). This means that CMOPF’s stock grew somewhat faster than CHGCF’s over the last 12 months.

CHGCF's Profit vs Risk Rating (83) in the null industry is in the same range as CMOPF (100). This means that CHGCF’s stock grew similarly to CMOPF’s over the last 12 months.

CHGCF's SMR Rating (41) in the null industry is somewhat better than the same rating for CMOPF (89). This means that CHGCF’s stock grew somewhat faster than CMOPF’s over the last 12 months.

CHGCF's Price Growth Rating (54) in the null industry is in the same range as CMOPF (61). This means that CHGCF’s stock grew similarly to CMOPF’s over the last 12 months.

CHGCF's P/E Growth Rating (65) in the null industry is in the same range as CMOPF (97). This means that CHGCF’s stock grew similarly to CMOPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHGCFCMOPF
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
38%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
20%
Momentum
ODDS (%)
Bearish Trend 3 days ago
56%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
6%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
49%
Bullish Trend 3 days ago
23%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
34%
Bullish Trend 3 days ago
23%
Advances
ODDS (%)
Bullish Trend 10 days ago
60%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
70%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
27%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
41%
Bullish Trend 3 days ago
25%
View a ticker or compare two or three
Interact to see
Advertisement
CHGCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLRRX12.230.15
+1.24%
NYLI Winslow Large Cap Growth Class R1
JIISX82.190.70
+0.86%
JPMorgan US Sustainable Leaders I
PORIX60.580.36
+0.60%
Trillium ESG Global Equity Institutional
FIJDX38.850.22
+0.57%
Fidelity Advisor Gold Z
UEIPX14.470.06
+0.42%
UBS Engage For Impact P

CHGCF and

Correlation & Price change

A.I.dvisor tells us that CHGCF and CHGCY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCF and CHGCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCF
1D Price
Change %
CHGCF100%
-9.99%
CHGCY - CHGCF
32%
Poorly correlated
-0.89%
CMOPF - CHGCF
10%
Poorly correlated
N/A
DSKYF - CHGCF
-2%
Poorly correlated
-2.39%
CHJTF - CHGCF
-3%
Poorly correlated
N/A
DSNKY - CHGCF
-5%
Poorly correlated
-2.41%
More

CMOPF and

Correlation & Price change

A.I.dvisor tells us that CMOPF and CHGCF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMOPF and CHGCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMOPF
1D Price
Change %
CMOPF100%
N/A
CHGCF - CMOPF
10%
Poorly correlated
-9.99%
CHGCY - CMOPF
5%
Poorly correlated
-0.89%
BAYZF - CMOPF
2%
Poorly correlated
-0.90%
GIFLF - CMOPF
1%
Poorly correlated
N/A
CHJTF - CMOPF
-0%
Poorly correlated
N/A
More